On-board conjugation
The on-board conjugation of detection agents with indicators in a labeling device addresses label interference and cost issues, enabling efficient and cost-effective labeling of multiple analytes.
Patent Information
- Application Number
- JP2024072005
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-04-28
- Filing Date
- 2024-04-26
- Publication Date
- 2024-11-08
AI Technical Summary
Existing methods for labeling multiple analytes face challenges such as interference between labels, high storage and transportation costs, and instability of labeled antibodies, particularly in multicolor FACS analysis.
A method involving on-board conjugation of detection agents with indicators immediately after preparation, using a labeling device to select and combine detection agents and indicators to minimize label interference, reducing the need for pre-manufactured conjugates.
This approach minimizes label interference and reduces storage and transportation costs by allowing flexible selection and combination of indicators, ensuring efficient and stable labeling of multiple analytes.
Smart Images

Figure 2024159670000003 
Figure 2024159670000001 
Figure 2024159670000002
Abstract
Description
[Technical field]
[0001] The present invention relates to a method for labeling an analyte in a sample, the method comprising: (a) providing a detection reagent that binds to the analyte and conjugating the detection reagent with an indicator reagent to form a conjugation product; and (b) contacting the sample with the conjugation product of step (a), wherein step (b) is performed immediately after completion of step (a), and wherein steps (a) and (b) are performed by the same labeling device; the present invention also relates to labeling devices, systems, and uses associated therewith. [Background technology]
[0002] Labeled antibodies have a wide variety of applications, especially in clinical and diagnostic applications, but also in life science research. While many applications require only one labeled antibody, there are more demanding applications in which two or more analytes need to be detected, for example in multicolor FACS analysis of cell populations. Multicolor labeling is often hindered by interference between labels, e.g., in fluorescence applications, fluorescence spillover, overlapping absorption spectra, and cross-excitation are well-known interference phenomena.
[0003] Examples of multicolor labeling include the 3- to 6-color panels used for HIV immunophenotyping, as outlined, for example, in Barnett et al. (2009), Nat Rev Microbiol 6(11 Suppl):S7 and the 6-color TBNK panel from BioLegend, but more complex panels have also been used, for example, in the analysis of acute myeloid leukemia (Ouyang et al. (2019), J Int Med Res 47(4):1483).
[0004] Labeled antibodies are usually provided by manufacturers, which means that each antibody / label combination must be obtained and stored, increasing storage and transportation costs. This effort increases exponentially as the number of antibodies and labels that can be used increases. Also, keeping a large number of antibody / label conjugates in stock can make combinations, especially those that are used infrequently, unusable due to, for example, on-board instability, open vial instability and / or closed vial instability, i.e., reaching their expiration date. Summary of the Invention
[0005] Therefore, there is a need in the art for improved means and methods for providing and storing detection agent / label conjugates, avoiding the above-mentioned drawbacks.The technical problem underlying the present invention can be seen as the provision of means and methods to address the above-mentioned needs.This technical problem is solved by the following claims and the embodiments characterized herein.
[0006] Thus, the present invention relates to a method for labeling an analyte in a sample, the method comprising the steps of: (a) providing a detection reagent that binds to an analyte and conjugating the detection reagent with an indicator reagent to form a conjugation product; (b) contacting the sample with the conjugation product of step (a); The step (b) is carried out immediately after completion of the step (a).
[0007] Generally, the terms used herein should be given their ordinary and customary meanings to those skilled in the art, and should not be limited to special or customized meanings unless otherwise indicated. The terms "have", "comprise", or "include" used below, or any grammatical variations thereof, are used non-exclusively. Thus, these terms may refer to both the situation where no further features are present in the entity described in this context, in addition to the features introduced by these terms, and the situation where one or more additional features are present. As an example, the expressions "A has B", "A comprises B", and "A includes B" may both refer to the situation where, apart from B, no other elements are present in A (i.e., A consists solely and exclusively of B), and the situation where, apart from B, one or more further elements are present in entity A, such as element C, elements C and D, or further elements. Also, as will be understood by those skilled in the art, in one embodiment, the terms "comprising a" and "comprising an" refer to "comprising one or more," i.e., equivalent to "comprising at least one." Thus, a reference to one item of a plurality, unless otherwise indicated, in one embodiment, refers to at least one such item, and in a further embodiment, the plurality, thus, for example, identifying a "cell," refers to identifying at least one cell, and in one embodiment, to identifying a multiplicity of cells. Also, the term "multiple" will be understood by those skilled in the art to refer to a number greater than one, i.e., in one embodiment, at least two, in a further embodiment, at least three, in a further embodiment, at least four, and in a further embodiment, at least five, and thus a multiplicity may be, for example, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 50, or 100.
[0008] Furthermore, when used hereinafter, the terms "preferably," "more preferably," "most preferably," "particularly," "more particularly," "specifically," "more specifically," or similar terms are used in conjunction with any feature without limiting further possibilities. Thus, features introduced by these terms are optional features and are not intended to constrain the scope of the claims in any manner. The invention may be implemented using alternative features, as one skilled in the art will recognize. Similarly, features introduced by "in one embodiment" or similar expressions are intended to be optional features, without any limitations on further embodiments of the invention, without any limitations on the scope of the invention, and without any limitations on the possibility of combining the feature so introduced with other optional or non-optional features.
[0009] The methods specified below are in vitro methods. The method steps may in principle be performed in any order deemed appropriate by those skilled in the art, but in one embodiment are performed in the specified order, and one or more of the steps, in one embodiment all of them, may be assisted or performed by automated equipment. Furthermore, the method may include steps other than those explicitly mentioned above.
[0010] As used herein, the term "standard conditions" refers to IUPAC standard ambient temperature and pressure (SATP) conditions, unless otherwise specified, i.e., preferably, a temperature of 25° C. and an absolute pressure of 100 kPa, and also preferably, the standard conditions include a pH of 7. Furthermore, unless otherwise indicated, the term "about" refers to the indicated value with a technical precision generally accepted in the relevant field, in one embodiment, to the indicated value ±20%, in a further embodiment, to ±10%, and in a further embodiment, to ±5%. Furthermore, the term "essentially" indicates that there is no deviation affecting the indicated result or use, i.e., potential deviations do not cause the indicated result to deviate by more than ±20%, in a further embodiment, to ±10%, and in a further embodiment, to ±5%. Thus, "consisting essentially of" means including the specified components, but excluding other components, except for materials present as impurities, unavoidable materials present as a result of the process used to provide the components, and components added for purposes other than achieving the technical effect of the present invention. For example, a composition defined using the phrase "consisting essentially of" encompasses any known acceptable additives, additives, diluents, carriers, and the like. In one embodiment, a composition consisting essentially of a set of components contains less than 5 wt.%, in a further embodiment less than 3 wt.%, in a further embodiment less than 1 wt.%, and in a further embodiment less than 0.1 wt.% of an unspecified component(s).
[0011] The term "fragment" of a biological macromolecule, in one embodiment of a polynucleotide or polypeptide, is used herein in a broad sense to refer to any subpart, in one embodiment a subdomain, of the respective biological macromolecule, comprising the indicated sequence, structure and / or function. The term therefore includes subparts generated by actual fragmentation of the biological macromolecule, but also subparts derived abstractly, for example in silico, from the respective biological macromolecule. Thus, as used herein, Fc or Fab fragments may be referred to as fragments of immunoglobulins. The term "derivative" is understood by the skilled person to refer to a compound having a structure that is not identical to the compound from which the derivative is derived, but has essentially the same activity. Thus, a derivative of an antibody may in particular be a humanized antibody, a bispecific antibody, a single chain antibody or a nanobody, all of which are in principle known to the skilled person.
[0012] The term "labeling" is understood by those skilled in the art in the context of the present specification to relate to any activity and / or process that allows the analyte to be detected, in particular by associating the analyte with an indicator as specified herein below. In one embodiment, the labeling is specific labeling, and the term "specific labeling" relates to a labeling that allows the distinction between analyte and non-analyte molecules. As will be understood by those skilled in the art, specific labeling does not necessarily allow the distinction between the analyte and any non-analyte molecules, and typically, a sample contains a limited number of non-analyte compounds, especially if the sample is enriched for the analyte, treated to remove non-analyte compound classes, e.g., polynucleotides and / or polypeptides, or pre-treated to reduce the complexity of the matrix. Thus, as used herein, specific labeling is, in one embodiment, specific in the context of a particular sample type and / or sample pre-treatment. In one embodiment, specific labeling is at least 5-fold, in a further embodiment at least 10-fold, in a further embodiment at least 25-fold, in a further embodiment at least 100-fold stronger labeling of the analyte compared to any non-analyte contained in the sample. Labeling is typically accomplished by binding a conjugate, as specified herein below, to the analyte, so that the indicator conjugated to the detection agent in the conjugate is non-covalently or covalently associated, in one embodiment non-covalently, with the analyte. Thus, the binding of the indicator to the analyte may in particular be indirect, i.e., via the detection agent. In one embodiment, as specified herein below in more detail, the analyte is contained in a larger structure that includes a number of chemical compounds, in particular cells such as eukaryotic cells, in which case the analyte may also be referred to as a "marker" or "surface marker". In such a case, it will be understood that the analyte molecules present in the cell and / or on the cell surface are labeled, and the cells are also labeled.In one embodiment, when multiple analytes are labeled in the same cell sample, such analytes may be contained in the same cell, for example in the case of double labeling of cells, for example CD3 and CD19 labeling, or may be present on different cell types, for example when labeling two different cell types, such as CD4+T cells and CD8+T cells. As will be appreciated by the skilled artisan, mixed labeling is also possible, for example when one analyte is present on a cell population and a second analyte is present only on a subgroup thereof, or when a first marker is present on a first cell population and a second marker is present on a second cell population, but both the first and second analytes may be present on a further, third cell population.
[0013] As used herein, the term "analyte" refers, in one embodiment, to a chemical molecule, an organic molecule, that binds to a detection agent with sufficient affinity to allow detection of the analyte / detection agent complex. In one embodiment, the dissociation constant (Kd) of the analyte / detection agent complex is at most 10 -7 mol / L, in further embodiments up to 10 -8 mol / l, in further embodiments up to 10 -9 mol / L. In one embodiment, the analyte is a biological molecule, and in a further embodiment, the analyte is a biological macromolecule. In a further embodiment, the analyte is a polypeptide. When the analyte is contained within a cell, such an analyte may be referred to as a "marker" or "biomarker."
[0014] In one embodiment, when the analyte is a polypeptide, the polypeptide is an antigen produced by an infectious agent, such as a virus, bacteria or protozoa, or the analyte is an antibody produced by a subject against an antigen produced by an infectious agent, such as a virus, bacteria or protozoa. However, the analyte may also be a non-antibody polypeptide, such as a folate binding protein or an endogenous factor, produced by a subject, which in one embodiment is the subject of diagnosis. In a further embodiment, the analyte is a polypeptide contained in a host cell, in particular exposed on the host cell surface. Thus, the analyte is in one embodiment a cell surface marker. Suitable cell surface markers are known in the art and described elsewhere herein. In one embodiment, the analyte is a marker used in CD4 immunophenotyping, for example in HIV-infected subjects, used in differentiation of white blood cells and / or platelets and / or red blood cells, for example in differentiation of TBNK, or used in differentiation of acute leukemia, in particular acute myeloid leukemia. Thus, the analyte may be CD3, CD4, CD8, CD45, CD56, CD16, and / or CD19, e.g., when used in TBNK differentiation, and / or CD13, CD15, CD33, CD61 and / or CD9, e.g., when used in acute leukemia differentiation, and / or CD3, CD4, CD8, CD19 and / or CD20, e.g., when used in HIV leukocyte analysis.However, the analyte may also be any other cell marker deemed suitable by the skilled artisan, including in particular CD3, CD4, CD8, CD10, CD19 and / or CD33, e.g. as a BLAST panel; CD11b, CD34 and / or HLA-DR (=human leukocyte antigen-DR isotypes, e.g. in APL (acute promyelocytic leukemia) screening; CD4, CD5, CD8, CD19 and / or CD20, e.g. in CD20 drug monitoring; CD41, CD61, CD62p and / or PS (phosphatidylserine, e.g. in PLT-function tests and treatments; and / or CD14, CD41, CD42a, CD61, CD62p and / or PS, e.g. in coronary artery disease / atherosclerosis diagnosis.
[0015] In one embodiment, the analyte is an antigen derived from a single-celled organism, such as a bacterial antigen, e.g., a Treponema pallidum antigen, a Borrelia antigen, a Brucella antigen, a Chlamydia antigen, a Mycoplasma antigen, a Listeria antigen, or, in one embodiment, a Trypanosoma cruzi antigen. In one embodiment, the analyte is an antibody against a bacterial antigen, in a further embodiment, an antibody against a bacterial polypeptide. In one embodiment, the antibody is an anti-Treponema pallidum antibody, an anti-Borrelia antibody, an anti-Brucella antibody, an anti-Chlamydia antibody, an anti-Mycoplasma antibody, or an anti-Listeria antibody. In yet another embodiment, the analyte is an antibody against a single-celled organism, in one embodiment, an anti-Trypanosoma cruzi antibody. In a further embodiment, the analyte is an anti-autoantibody, i.e., an antibody that recognizes an antigen produced by the subject itself, in one embodiment, an anti-autoantibody for diagnosis and / or prognosis of a disease, in one embodiment, an autoimmune disease. Diagnostic and prognostic anti-autoantibodies are known in the art and include, for example, antinuclear antibodies, which indicate systemic lupus erythematosus or polymyositis, antithyroid antibodies, which indicate Hashimoto's thyroiditis or Graves' disease, anti-intrinsic factor antibodies, which indicate anemia, and anti-tissue transglutaminase antibodies, which indicate celiac disease or gluten sensitivity.
[0016] In one embodiment, the analyte is a viral antigen, such as an antigen of a virus, in one embodiment selected from the list consisting of hepatitis virus, arbovirus, adenovirus, coxsackievirus, echovirus, influenza virus, parainfluenza virus, cytomegalovirus, herpes virus, Epstein-Barr virus, mumps virus, norovirus, rotavirus, rubella virus, measles virus, human immunodeficiency virus, varicella zoster virus, poliovirus, coronavirus, and enterovirus. In one embodiment, the analyte is an antibody against a viral antigen, in a further embodiment against a viral polypeptide, or in a further embodiment against a viral capsid polypeptide, in one embodiment of a medically relevant virus, in one embodiment selected from the list specified herein above. In one embodiment, the virus is hepatitis A virus, hepatitis B virus, hepatitis C virus. In one embodiment, the viral capsid polypeptide is a hepatitis virus capsid polypeptide, in one embodiment a hepatitis A (HA) virus capsid polypeptide. Thus, the analyte, in one embodiment, is an antibody against a Hepatitis virus capsid polypeptide, for example against a Hepatitis A virus capsid polypeptide.
[0017] In one embodiment, the analyte is a protozoan antigen, e.g., from Toxoplasma, in one embodiment T. gondii. In one embodiment, the analyte is an antibody to a protozoan antigen, and in a further embodiment an antibody to a protozoan polypeptide. In one embodiment, the analyte is an antibody to T. gondii p30 polypeptide (Genbank Session No. S85174.1).
[0018] However, it is also envisaged that the analyte is a low molecular weight compound that can be determined by complex formation with a detection agent, in particular an antibody or a fragment thereof. In one embodiment, the analyte has a molecular mass of at least 100 (corresponding to 100 atomic mass units, corresponding to 100 Da; 1 Da is equivalent to 1.66×10−27 kg), in a further embodiment at least 250, in a further embodiment at least 500, or in a further embodiment at least 1000. In one embodiment, the analyte is thyroxine (T4), triiodothyronine (T3), folic acid, or vitamin B12.
[0019] As used herein, the term "sample" relates to any sample known or suspected to contain at least one analyte. The sample may be a liquid, semi-solid, solid or gas sample, in one embodiment a liquid, semi-solid or solid sample, that contains or is suspected to contain at least one analyte. In one embodiment, the sample is a biological sample. Thus, the sample may be, for example, a sample containing cells, in one embodiment a host cell as specified herein below, so that the sample may be cell culture medium or harvested cultured cells. In one embodiment, the sample is a sample of a subject, such as a sample from a body fluid, tissue or organ, or a sample of a lavage / rinse or a swab or smear obtained from an external or internal surface. In one embodiment, the sample is a blood, plasma, serum, urine, saliva or tear sample. The sample may be obtained by the use of a brush, (cotton) swab, spatula, rinse / rinse, punch biopsy device, puncture of a body cavity with a needle or lancet, or by a surgical instrument. However, in one embodiment, samples obtained by other known techniques, including scrapings, swabs or biopsies from the urogenital tract, perianal region, anal canal, oral cavity, upper aerodigestive tract and epidermis, are also included as samples of the present invention. In one embodiment, the sample is a sample containing the cells of the subject, but cell-free fluids may also be obtained from the aforementioned body fluids, tissues or organs by lysis techniques (e.g., homogenization, etc.) and / or separation techniques (e.g., filtration or centrifugation, etc.). In one embodiment, the sample is obtained from a body fluid known or suspected to contain one or more analyte(s). In one embodiment, the sample is an easily accessible sample, in one embodiment, blood, plasma, serum, saliva, etc., or a sample derived therefrom, such as a sample of blood cells, particularly white blood cells, in one embodiment, peripheral blood monocytes (PBMCs). It should be understood that the sample may be further processed to carry out the method. In particular, cells or specific cell types may be obtained or removed from the sample by methods and means known in the art. Additionally, at least one analyte may be extracted and / or purified from the sample by methods and means known in the art.As will be appreciated by those of skill in the art, the specific method(s) of sample pretreatment will depend, for example, on the type of sample, e.g., a gas sample may require extraction of an analyte into a liquid medium prior to further use. Thus, the term sample may also relate to a preparation that contains or is suspected of containing at least one analyte that has been diluted, concentrated, purified and / or extracted from the sample.
[0020] As used herein, the term "host cell" refers, in one embodiment, to a eukaryotic cell known or suspected to contain at least one analyte. In one embodiment, the host cell is a vertebrate cell, in a further embodiment a mammalian cell, and in a further embodiment a human cell.
[0021] As used herein, the term "detection agent" refers to a compound that comprises a structure that directly or indirectly binds to an analyte, in one embodiment, specifically binds to the analyte. In one embodiment, the detection agent and any additional detection agent, and optionally any further detection agents, are not identical to each other.
[0022] The detection agent may be an indirect detection compound, i.e. a detection agent that does not directly contact the analyte but uses a further compound that itself binds to the analyte, thus the detection agent may be, for example, an anti-antibody antibody that binds to an anti-analyte antibody. In one embodiment, the detection agent is a direct detection agent, i.e. an agent that directly binds to the analyte. In one embodiment, the detection agent is an antibody or an analyte-binding fragment or derivative thereof, in one embodiment an IgG or a fragment thereof. In one embodiment, the detection agent is a monoclonal antibody.
[0023] In one embodiment, the detection agent comprises at least one affinity domain, the term "affinity domain" referring to a substructure of the detection agent that mediates the affinity of the detection agent for the analyte. Thus, the affinity domain is the substructure of the detection agent that comprises the atoms that contact the analyte in the detection agent / analyte complex. The affinity domain may comprise, for example, in one embodiment, two or more affinity domains, for example, when the affinity domain is an IgG, in a further embodiment, ten identical affinity domains, for example, when the affinity domain is an IgM, in a further embodiment, two different affinity domains, when the affinity domain is a diabody. In a further embodiment, when the affinity domain is a polyepitopic antigen, the affinity domain may comprise a number, i.e. any number, of at least two identical or non-identical affinity domains. The detection agent may comprise, for example, a further domain, for example, a structural domain not involved in the binding of the analyte, for example, the Fc domain of an antibody, when it is a polypeptide. In one embodiment, the affinity domain of the first detection agent is not identical to the affinity domain of the second detection agent. Thus, in one embodiment, the first and second detection agents may be different monoclonal antibodies which, in one embodiment, recognize different analytes or different epitopes of the same analyte.
[0024] In one embodiment, the detection agent further comprises one or more linking group(s), the term "linking group" referring to any chemical group that allows for coupling of the detection agent with the indicator agent. Thus, the linking group, in one embodiment, comprises at least one reactive or activatable chemical group that allows for the formation of a new chemical bond to a reaction partner. Suitable chemical groups and associated chemistries are known in the art, and the skilled artisan will select the appropriate group and chemistry depending in particular on the chemical nature of the detection agent and the indicator agent. As will be understood by the skilled artisan, the linking group may be a chemical group already present in the detection agent, such as an amino group or a sulfhydryl group in a polypeptide. The linking group may further comprise a linker, i.e., a chemical group extended in one direction that increases the distance and / or flexibility between the detection agent and its coupling partner, in one embodiment the indicator agent.
[0025] In one embodiment, the coupling between the detection agent and the indicator agent is non-covalent, and thus in one embodiment the detection agent comprises one partner of an affinity pair. The term "affinity pair" is understood by those skilled in the art. In one embodiment, the term refers to a pair of compounds, in one embodiment polypeptides, that form a complex in aqueous solution under standard conditions. In one embodiment, the complex between the members of the affinity pair is at most 10 -9 mol / l, in one embodiment up to 10 -10 mol / l, in further embodiments up to 10 -11 mol / l, in further embodiments up to 10 -12 mol / l, in further embodiments up to 10 -13 mol / l, in further embodiments up to 10 -14 The affinity pair has a dissociation constant of 100 mol / l. In one embodiment, the affinity pair comprises a first affinity partner and a second affinity partner, which in further embodiments are specified elsewhere in this specification. Affinity pairs are in principle known in the art, in particular biotin-streptavidin affinity pairs and affinity pairs derived therefrom, such as strep-tag and streptactin derivatives, digoxigenin and anti-digoxigenin (i.e. antibodies against digoxigenin) pairs, colicin immune pairs, etc. However, in principle any pair of compounds with sufficient affinity and specificity may be used, including, for example, myc-tag-antibody and flag-tag-antibody pairs.
[0026] As referred to herein, the terms "first partner of the affinity pair" and "first affinity partner", "second partner of the affinity pair" and "second affinity partner", "one affinity partner" and "other affinity partner" are used herein only to distinguish the two partners of the affinity pair, and thus the expression "first partner" is not related to any temporal or spatial relationship with other compounds, but is used only to distinguish it from the "second partner" of the affinity pair. The first affinity partner and the second affinity partner and the one affinity partner and the other affinity partner together respectively constitute the affinity pair as specified herein above. The foregoing applies mutatis mutandis to the terms "detection agent" and "additional detection agent", "indicator agent" and "additional indicator agent", as well as the terms "first reaction vessel", "second reaction vessel", and "third reaction vessel", and similar expressions.
[0027] As used herein, the term "indicator" refers to a compound adapted to enable detection of the presence of a molecule or complex containing said indicator. Typically, an indicator has a detectable property, in one embodiment a detectable physical and / or chemical property. In one embodiment, the indicator and any further indicator(s) used in the method are not identical to each other.
[0028] As used herein, the term "physical property" refers to any property detectable by physical means, including in particular optical properties, electrochemical properties, and radiation emission. As used herein, the term "optical property" refers to any property that can be detected by optical instruments. Specifically, the optically detectable property can be or include at least one property selected from the group consisting of reflection properties, transmission properties, emission properties, scattering properties, fluorescence properties, fluorescent properties, diffraction properties, and polarization properties. Thus, optical properties contemplated by the present invention are, for example, color, fluorescence, luminescence, or refraction. In one embodiment, the optically determinable property referred to herein refers to a property of a compound that can be optically detected, such as light absorption, luminescence, light transmissibility, or properties related thereto. It will be understood that detection of an optically determinable property as used herein encompasses detection of the presence of a previously undetectable property, detection of the absence of a previously detected property, and detection of a quantitative change in the property, i.e., detection of a change in signal intensity that correlates to the degree of change in at least one optical property. Thus, the indicator, in one embodiment, is or comprises a fluorophore selected from the list consisting of DAPI, fluorescein, rhodamine, eosin, CF4055™, Brilliant Violet 510™, CF488A™, APC-Vio770™, or StarBright Violet 610™. It is understood that the term "optically determinable property" also relates, in one embodiment, to electrochemiluminescence, also known as electrogenerated chemiluminescence.
[0029] As used herein, the term "chemical property" in one embodiment relates to any characteristic detectable by at least one chemical reaction, e.g., activity to produce a chemical compound, when a co-substrate and / or catalyst is provided, and as referred to herein, the chemical property may be a catalytic activity, e.g., enzymatic property. As used herein, the term "enzymatic property" relates to the property of an indicator to produce a detectable product from a substrate by biological catalysis. Thus, the enzymatic property is typically conferred by the presence of a polypeptide having said enzymatic property in said indicator. Typically, the enzymatic property is selected from the group consisting of phosphatase activity (e.g., in alkaline phosphatase), peroxidase activity (e.g., in horseradish peroxidase), and glycosidase activity (e.g., in beta-galactosidase). Exemplary substrates for enzymatic activity are well known in the art. Typically, said enzymatic activity produces a product having a determinable optical property as specified herein above, or / and said enzymatic activity produces a product determinable by an electrical instrument.
[0030] The term "conjugate" is understood by those skilled in the art. As used herein, the term relates to the formation and / or provision of a covalent or non-covalent bond between chemical molecules to provide, in one embodiment, a conjugate. The bond is stable to allow the conjugate to be detected, in one embodiment, by a detectable property of the indicator. Thus, in one embodiment, the conjugate has a dissociation constant lower than the dissociation constant for the analyte-binder complex, in one embodiment, both within the range described for the affinity pair specified herein above. In a further embodiment, conjugating is the formation of at least one covalent bond between chemical molecules to provide a conjugate. In one embodiment, conjugating is the formation and / or provision of a conjugate between a detection agent and an indicator agent.
[0031] In accordance with the above, the term "conjugation product", which may also be referred to as "conjugate", relates to any chemical molecule or complex of chemical molecules comprising at least one binding agent and at least one indicator, in one embodiment all as specified herein above, formed by conjugation. Thus, the conjugate may in particular be a dye-labeled binding agent, such as a dye-labeled antibody or a fragment thereof. The conjugate may be purified, for example to remove unconjugated binding agent and / or indicator, and the conjugate may also be pretreated before use, for example to protect and / or neutralize any unreacted linking group or other reactive group, but in one embodiment the conjugate is used in the method of the invention as a preparation obtained in the conjugation step, i.e. in one embodiment without any intervening purification and / or pretreatment steps.
[0032] The term "contacting" as used in the context of the methods specified herein is understood by those skilled in the art. In one embodiment, the term relates to physically contacting at least one compound, particularly a conjugate, with a sample and / or a further compound, thereby, for example, allowing the sample to interact with the compound.
[0033] As will be understood by those skilled in the art in view of the description herein, the term "directly" has a component related to spatial / sequence in time. Thus, the phrase "performing step (b) directly after completion of step (a)" refers in one embodiment to (i) performing step (b) in a timely manner directly after completion of step (a), (ii) performing step (b) in the sequence of steps of the method directly after completion of step (a), (iii) performing step (b) on the same device in which step (a) is performed, or any combination of (i)-(iii), in particular all of the foregoing. As used herein, the term "timely" is used broadly and relates to a time frame of up to 1 day, in one embodiment up to 12 hours, in a further embodiment up to 6 hours, in a further embodiment up to 3 hours, in a further embodiment up to 1 hour, in a further embodiment up to 0.5 hours, and in a further embodiment up to 0.25 hours, after completion of step (a). In a further embodiment, the term timely relates directly to the shortest time frame technically possible. As understood by those skilled in the art, the shortest time frame technically possible is, in one embodiment, the period of time required by an operator or device to add a conjugate to a sample after completion of step (a), and for the avoidance of doubt, the term "after completion of step (a)" referred to herein relates to a time frame that begins when it is detected or determined that step (a) is complete. The term "directly in the step sequence" is understood by those skilled in the art. In one embodiment, this term relates to the fact that the next step after completion of step (a) is step (b), i.e., in one embodiment, there is no intervening step between steps (a) and (b). As referred to herein, the relevant steps in determining the order of steps relate to detection agents, indicators, and / or sample handling. Thus, in the methods referred to herein, any ancillary or unrelated steps may also be performed between steps (a) and (b) such that the order is directly determined; such ancillary or unrelated steps may for example be discarding excess reagent(s) to waste or transferring the sample to a reaction vessel, for example a second reaction vessel as specified herein above.According to the above, in one embodiment, step (a) is carried out in a first reaction vessel, and immediately carrying out comprises contacting the conjugate from step (a) with a sample in a second reaction vessel, and the conjugate from step (a) is not brought into contact with any further vessel before step (b). In such a case, the conjugation product of step (a) can be transferred from the first reaction vessel to the second reaction vessel, and in one embodiment, the conjugate exclusively contacts the first reaction vessel, the pipetting means, and the second reaction vessel and the sample during steps (a) and (b). In one embodiment, carrying out step (b) immediately after the completion of step (a) comprises contacting the conjugate with the sample within one of the time frames indicated herein above, and step (b) is carried out without an intervening step after the completion of step (a). Thus, in particular, the conjugate is not stored for a long period of time in one embodiment, and in particular the storage is within one day. In a further embodiment, the conjugate is specially prepared for a detection reaction or a series of detection reactions in which at least the analyte detected by the conjugate is common to all detection reactions. The term "on the same device in which step (a) is performed" is understood by the skilled person and in one embodiment relates to the fact that both steps (a) and (b) are performed on the same device. In one embodiment, said device is a labeling device as specified herein below.
[0034] Methods of the invention that include providing a detection reagent that binds to an analyte and conjugating the detection reagent with an indicator reagent to produce a conjugation product, followed by direct use of the conjugation product as specified herein, may also be referred to herein as "on-board conjugation."
[0035] As used herein, the term "subject" refers to a vertebrate, in one embodiment, a mammalian subject. In one embodiment, the subject is a livestock, companion animal, or laboratory animal, such as a cow, sheep, goat, horse, cat, dog, guinea pig, mouse, or rat. In one embodiment, the subject is a human. In a further embodiment, the subject is a human suspected of containing an analyte as specified herein.
[0036] The methods for labeling an analyte in a sample described herein include step (a) providing a detection reagent that binds to the analyte and conjugating the detection reagent with an indicator reagent to form a conjugation product.
[0037] The term "providing a detection agent" is understood by those skilled in the art as relating to making available for further use. In one embodiment, providing is making the detection agent physically available. The detection agent is, in one embodiment, a detection agent known to bind to the analyte, and thus, in one embodiment, providing a detection agent does not include identifying the detection agent, for example, in a screening method. Typically, providing a detection agent may be, inter alia, ordering and receiving a commercially available detection agent or manufacturing a detection agent known to bind to the analyte.
[0038] Conjugating the detection agent and the indicator agent is described herein above.The product of said conjugation, i.e. the conjugate, may be used in step (b) as obtained in the conjugating step, or may be purified and / or pretreated as described herein above.In one embodiment, the conjugate is used in step (b) as obtained in the conjugating step.
[0039] The method for labeling an analyte in a sample described herein further comprises a step (b) of contacting the sample with said conjugation product of step (a). The term contacting has been specified herein above. In one embodiment, the term relates to physically contacting the conjugate with the sample. Depending on the assay format selected, step (b) may comprise contacting the aforementioned compound with further compounds and elements, for example, in an assay that relies on the binding of the complex to a solid surface to remove uncomplexed sample components, the mixture may be further contacted with the solid surface. Also, in an assay in which the analyte is contained in or on the surface of a cell, step (b) may further comprise contacting the cell with a solid surface, for example, of a bead, to allow separation of the cell from the sample components and / or reagents of step (a) and / or step (b). Also, step (b) may comprise contacting the sample with further reagents, such as, inter alia, buffers, osmotic stabilizers, salts, nutrients, etc. As described herein, step (b) is carried out immediately after completion of step (a).
[0040] In one embodiment, the method for labeling an analyte in a sample described herein comprises the additional step (a1) of providing an additional detection reagent that binds to an additional analyte, and the additional step of conjugating the additional detection reagent with an additional indicator reagent to produce an additional conjugation product, where step (b) comprises contacting the sample with the conjugation product of step (a) and the additional conjugation product of step (a1), where step (b) is performed immediately after completion of at least one of the providing and conjugating steps. Also, step (a1) is typically performed spatially separate from step (a), and in one embodiment, in a separate reaction vessel. Thus, in one embodiment, the conjugating step (a) is carried out in a first reaction vessel, and step (a1) is carried out in a third reaction vessel, and immediately carrying out includes contacting the conjugate from step (a) and (a1) with the sample in the second reaction vessel, and in one embodiment, the conjugate from step (a) and / or the conjugate from step (a1) is not contacted with any further vessel before step (c). Thus, in one embodiment, the detection agent, at least one additional detection agent, and in one embodiment, the sample are contacted simultaneously in step (b). However, in one embodiment, it is also envisaged that the sample is contacted with the detection agent and the additional detection agent sequentially in any order deemed appropriate by the skilled artisan. In a further embodiment, the method further comprises at least one further step (a2) of providing a further detection reagent that binds to a further analyte and a further step of conjugating the further detection reagent with a further indicator reagent to produce a further conjugation product, wherein step (b) comprises contacting the sample with the conjugation product of step (a), the additional conjugation product of step (a1), and at least one further conjugation product of step (a2), and in one embodiment step (b) is performed immediately after completion of at least one of the providing and conjugating steps.Any additional conjugates, as this term is used herein, may in principle be provided in pre-manufactured form, for example commercially available, so that only the conjugates of step (a) are directly contacted with the sample. However, in one embodiment, at least two, in one embodiment all, of the conjugates are provided in contact with the sample and conjugated as specified for step (a), and in one embodiment, the contacting of at least two, in one embodiment all, of the conjugates is carried out immediately after the completion of the conjugation specified herein above. Thus, in one embodiment, in the method for labeling an analyte in a sample, at least two, in one embodiment all, of the conjugates are produced immediately before the contacting step. Thus, in one embodiment, the method relates to contacting a sample with multiple conjugates, in one embodiment to label multiple analytes. The additional detection agent is typically not the same as any additional detection agent used in the method, and the additional indicator agent is typically not the same as any further indicator agent used in the method.
[0041] In one embodiment, the indicator, the additional indicator, and optionally any further indicator are selected such that interference between the indicators is reduced, which in one embodiment is selected from the list consisting of fluorescence spillover, absorption spectrum overlap, and cross-excitation. In one embodiment, the reduction of interference is at least 25%, in one embodiment at least 50%, and in a further embodiment at least 75% of the interference, although the reduction may be a complete reduction, i.e., elimination of the interference. As one skilled in the art will appreciate, it may be sufficient that at least one of the aforementioned interferences is reduced as specified.
[0042] Unless otherwise stated herein, the specified compounds, in particular the analytes, detection agents, indicator agents and their conjugates, may be included in a larger structure, e.g., may be covalently or non-covalently linked to further molecules or substructures. In particular, the specified detection agents may be included in a fusion polypeptide that includes a further peptide that may function as a linker, e.g., as a tag for purification and / or detection, or may be a partner of an affinity pair as specified elsewhere herein. The term "detectable tag" refers to a stretch of amino acids that is added or introduced into a fusion polypeptide, in one embodiment the tag is added to the C-terminus or N-terminus of the fusion polypeptide. The stretch of amino acids in one embodiment allows the detection of the polypeptide by an antibody that specifically recognizes the tag, or in one embodiment allows the formation of a functional conformation, such as a chelator, or in one embodiment allows visualization, e.g., in the case of a fluorescent tag. Preferred detectable tags are Myc tags, FLAG tags, 6-His tags, HA tags, GST tags or fluorescent protein tags, e.g., GFP tags. All these tags are well known in the art.
[0043] Advantageously, in the research underlying the present invention, it has been found that the conjugate between the detection agent and the indicator agent can be synthesized, for example, on board the labeling device specified herein below. Such a procedure not only allows for a regulated selection of the indicator agent to reduce interference between the indicator agents, but also allows for the selection of the indicator agent according to availability, for example, providing improved and more efficient reagent management. Thus, the latter option allows for the use of indicator reagents that would have to be discarded if provided as pre-manufactured conjugates that may not be used up by the date of use. For the former, the method also allows for the selection of a preferred combination of indicator agents, facilitating the separation of detection channels between the indicator agents.
[0044] The above definitions apply mutatis mutandis below. The following further additional definitions and explanations also apply mutatis mutandis to all embodiments described herein.
[0045] The present invention further comprises: (A) a first container containing a detection reagent, operably connected to a reaction unit; (B) a second container containing an indicator, operably connected to the reaction unit; (C) a label unit; The labeling device includes a reaction unit configured to conjugate the detection reagent with an indicator reagent to generate a conjugation product, and the labeling unit configured to contact a sample with the conjugation product.
[0046] As used herein, the term "labeling device" refers to a system of means comprising at least the described means operatively linked to each other to allow conjugation and labeling. Exemplary means for conjugating detection and indicator reagents are known in the art and described herein above in the context of the method of the invention. In one embodiment, the means for conjugating comprises a reaction vessel, such as at least the first and second reaction vessels specified herein above. However, it is also envisaged that the sample is added to the conjugate immediately after conjugation to the vessel in which the conjugation is carried out, and thus the device may comprise only one reaction vessel. In a further embodiment, the device comprises multiple reaction vessels, which in one embodiment are disposable, and thus the reaction vessel may be, for example, a multi-well plate. In one embodiment, the labeling device is adapted to carry out a method, including the method for labeling an analyte in a sample specified herein above. Thus, in one embodiment, the labeling device further includes a processor and, in one embodiment, tangibly embodied instructions which, when executed on the processor, cause the labeling device to perform the steps of the methods for labeling analytes in a sample as specified elsewhere herein.
[0047] The labeling device includes a reaction unit. As used herein, the term "reaction unit" refers to a unit of the device that includes a means for conjugating the detection reagent with the indicator reagent to generate a first conjugation product, and in one embodiment, the conjugation is performed in a first reaction vessel, and the detection reagent and the indicator reagent are transferred to the reaction vessel via a pipetting mechanism. As the skilled person will understand in view of the above description herein, the reaction unit includes a means for performing two or more conjugations in one embodiment, a plurality of conjugations in one embodiment, at least two, in a further embodiment, at least three, and in a further embodiment, at least four conjugations. The conjugations are performed in one embodiment simultaneously or in overlapping time frames, and thus the reaction unit includes, in one embodiment, multiple reaction vessels and corresponding pipetting mechanisms.
[0048] The labeling device comprises a labeling unit, and when referred to herein, the term "labeling unit" relates to any unit adapted to contact a conjugate as specified herein above with a sample. Thus, the labeling unit in one embodiment comprises a reaction vessel, for example a second reaction vessel as described herein above, and a pipetting mechanism allowing the sample and / or at least one conjugate to be transferred to said reaction vessel. Depending on the type of labeling to be performed, the labeling unit may comprise further elements such as a magnet for performing magnetic bead assisted cell sorting or for immobilizing a complex comprising a detection agent, an indicator agent and an analyte. However, when the term is referred to herein, the term labeling unit relates to any unit adapted to contact a conjugate as specified herein above with a sample, which in one embodiment allows the formation of a complex comprising an analyte, a detection agent and an indicator agent. Depending on the intended further use of the labeled analyte, the removal of excess reagents and / or non-analyte sample constituents (matrix) may be optional.
[0049] In one embodiment, the labeling unit is operatively connected to an analysis unit comprising a detector, which in one embodiment is adapted to detect the conjugation product by a detectable property of the indicator. Suitable means are known in the art and include in particular photometers, fluorometers, digital imaging units, microscopes such as digital microscopes, light-optical units such as in-stream imaging units of fluorescence-activated cell sorting (FACS) devices, and similar units. Digital microscopes and means for preparing slides for automated evaluation are described, for example, in US Pat. No. 9,017,610 B2. The detector may further comprise means for separating the complexes containing the indicator from other compounds, in particular matrix components, non-labeled cells, etc. Thus, the detector may be, for example, a cell sorting unit, in one embodiment a FACS unit.
[0050] In one embodiment, the labeling device further comprises a selector unit. As referred to herein, the term "selector unit" refers to a unit adapted to select one or more combinations of detection agent and indicator agent for conjugation. Thus, the selector unit, in one embodiment, comprises a tangibly embodied algorithm for selecting an indicator agent for conjugation with a detection agent, in one embodiment, for selecting at least a first indicator agent for conjugation with a first detection agent and a second indicator agent for conjugation with a second detection agent. In one embodiment, the selection is one in which the interferences specified herein above are reduced or completely avoided, and thus the selector unit may further comprise, and preferably be tangibly incorporated, a database that includes data on indicator compounds that are assigned to interfering indicator compounds and / or data on interferences.
[0051] The labeling device may also comprise an evaluation unit, the term "evaluation unit" relating to a unit adapted to process and optionally analyze the data generated by the analysis unit. The evaluation unit of the device thus comprises in one embodiment a memory unit comprising at least one tangibly embodied algorithm for evaluating the data received by the evaluation unit from the analysis unit. Suitable evaluation units are known in the art, e.g. units of ELISA meters, FACS machines, automated microscope slide analyzers, etc.
[0052] Further units of the apparatus that may be present optionally may relate to the requirements of the intended conjugation and labeling reaction. That is, for example, when conjugating via affinity pair, in one embodiment, it may be sufficient to mix under standard conditions the detection agent bound to the first partner of the affinity pair with the indicator agent bound to the corresponding second partner of the affinity pair. On the other hand, coupling via a chemical reaction forming a covalent bond between the detection agent and the indicator agent may require deviations from the standard conditions, such as increasing and / or decreasing the temperature, increasing and / or decreasing the pH, vigorous stirring, etc. Similarly, labeling may require modified conditions and / or additional reagents. Thus, in one embodiment, the reaction unit and / or labeling unit further comprises a heating unit, a cooling unit, one or more co-reactant(s) and / or catalyst(s), buffers, diluents and / or stoppers, agitators, shakers and / or pipetting units, which are independently selected.
[0053] Further units of the device which may be optionally present may relate to further functions which may be performed by the device, such units may in particular be a control unit for controlling further functions and / or units of the device, such as a washing unit for separating the complex comprising the analyte, the detection agent and the indicator agent from the sample constituents, from uncomplexed detection agent and / or from uncomplexed indicator agent; output units such as a monitor, a printer, a network connection and / or other means for transmitting information to a user and / or to one or more connected devices; input units; and / or data storage units such as a memory, or a mass storage device and / or a data interface to an external data storage device.
[0054] How the means of the labeling device are connected in an operational manner depends on the type of means included in the labeling device. In one embodiment, the means are included in a single device. However, it is also contemplated that the means of the present invention may appear as separate devices in one embodiment and are packaged together as a kit in a further embodiment. A person skilled in the art will understand how to connect the means without further difficulty. A preferred device is one that can be applied without the special knowledge of a specialist. In one embodiment, the device is adapted to include the additional features described herein.
[0055] The present invention also provides a method for manufacturing a device comprising: (i) a signage device according to the present invention; (ii) a detection device and / or a selector device.
[0056] The labeling device is described herein above. As used herein, the term "detection device" refers to any device that is equipped with the detector specified herein above in a separate device, and may be a FACS device or a digital imaging device in particular. Similarly, as used herein, the term "selector device" refers to any device that is equipped with the selector unit specified herein above in a separate device. As those skilled in the art will understand, the labeling device that is part of the system specified herein does not include a detector and / or does not include a selector unit in one embodiment.
[0057] In the system, the devices are operatively connected. Given the description provided herein, the skilled person knows how to operatively connect the devices of the system. In one embodiment, the detection device is connected to the labeling device by a fluid connection, which may be any means adapted to transfer fluid from one device to another, such as one or more tubes with any pump, or a transport mechanism for transporting one or more reaction vessels, such as a transport belt or a robotic arm. The operative connection between the labeling device and the selector device may be a data transfer connection, since the selector device may provide the label with data regarding one or more combinations of detection agent(s) and indicator agent(s). Thus, the selector device may be any device including a means adapted to select one or more combinations of detection agent(s) and indicator agent(s) for conjugation. Thus, the selector device may in principle be any device comprising a processor and at least one suitable algorithm and, if necessary, a database, both as specified herein above. Thus, the device may be, for example, a suitably adapted mobile device, such as a mobile phone or tablet computer, or a desktop computer, connected to the labeling device via a data transfer connection.
[0058] The present invention also provides, in one embodiment, a computer-implemented method for selecting at least two indicator reagents for labeling two analytes with two detection reagents, comprising: (I) obtaining data regarding available indicators; and (II) obtaining data regarding the analyte; and (III) selecting at least two indicators based on the data obtained in steps (I) and (II), said selection comprising: - Reducing or preventing fluorescence spillover, - reducing or preventing overlap of absorption spectra, - reducing or preventing cross-excitation. - selecting at least two indicators based on the data obtained in steps (I) and (II), the indicators satisfying at least one condition selected from the list consisting of:
[0059] The selection method of the present invention is an in vitro method, and in one embodiment, an in silico method. Moreover, the method may include steps other than those explicitly mentioned above. Moreover, one or more of the steps may be assisted or performed by an automated device. In particular, the method may be carried out in a labeling device or a selector device, as specified elsewhere herein.
[0060] The term "data of available indicator reagents" is understood by those skilled in the art. In one embodiment, the term relates to data on indicators available for conjugation with detection reagents as specified herein above. Such data may relate to indicators that are available in principle, e.g., commercially available, and in one embodiment, the term relates to indicators that are accessible for conjugation when the selection method is performed. Thus, the data on available indicators may relate in particular to indicators available in a particular laboratory or in a particular device. Thus, if the indicator compound has optically detectable properties, the data provided for the indicator may be, for example, available volume, expiration date, indicator identifier, absorption maximum or absorption maxima, absorption range, absorption spectrum, emission maximum or emission maxima, and / or emission range.
[0061] The term "data relating to an analyte" is also understood by those skilled in the art. In one embodiment, the data is data relevant to the selection of indicator(s), such as, for example, expected concentration range of the analyte(s), photo-optical properties of the analyte(s), possible reactivity with indicator reagents, etc. If more than one indicator reagent is planned to be used, such data may also include data regarding multiple identical and / or non-identical markers in or on the analyte, e.g., cells, of interest.
[0062] The term "fluorescence spillover" is known to those skilled in the art to refer to the emission of a first indicator in the wavelength range used to detect a second indicator. The term "absorption spectrum overlap" is known to those skilled in the art to refer to the fact that a first and a second indicator may have overlapping absorption spectra, such that excitation in the overlapping range may result in a reduction in the excitation of one or both of the indicator(s). The term "cross-excitation" is known to refer to the fact that the emission by a first indicator may be in the absorption range of a second indicator reagent, causing unintended excitation of the second indicator.
[0063] As mentioned herein, the measures to avoid the aforementioned interferences relate to the selection of indicators and therefore in one embodiment not to device-side compensation methods such as use of filters, demixing, etc. Thus, the aforementioned conditions are met by a proper selection of indicators, in particular such that the emission ranges do not overlap between at least two, and in one embodiment all, of the indicators, the absorption ranges do not overlap between at least two, and in one embodiment all, of the indicators, and / or the emission range of a first indicator does not overlap with the excitation range of a second indicator.
[0064] The present invention also relates to the use of on-board conjugation to generate at least two detection reagents, including non-identical indicator reagents, on an apparatus comprising an analysis unit and a detector.
[0065] The present invention further discloses and proposes a computer program comprising computer executable instructions for carrying out the method according to the present invention in one or more of the embodiments attached hereto when the program is executed on a computer or a computer network. In particular, the computer program may be stored on a computer readable data carrier. Thus, in particular, one, more than one or all of the method steps a) to d) as described above may be carried out using a computer or a computer network, in one embodiment, using a computer program.
[0066] The present invention further discloses and proposes a computer program product having program code means for carrying out the method according to the present invention in one or more embodiments contained herein when the program is executed on a computer or a computer network. In particular, the program code means may be stored on a computer readable data carrier.
[0067] Furthermore, the present invention discloses and proposes a data carrier storing a data structure which, after being loaded into a computer or a computer network, such as for example the working or main memory of the computer or computer network, is capable of carrying out the method according to one or more of the embodiments disclosed in this specification.
[0068] The present invention further proposes and discloses a computer program product having program code means stored on a machine-readable carrier for performing the method according to one or more of the embodiments disclosed herein when the program is executed on a computer or a computer network. As used herein, a computer program product refers to a program as a tradeable product. The product generally exists in any format, such as a paper format, or on a computer-readable data carrier. In particular, the computer program product may be distributed over a data network.
[0069] Finally, the present invention proposes and discloses a modulated data signal containing instructions readable by a computer system or computer network for carrying out the methods according to one or more of the embodiments disclosed herein.
[0070] In one embodiment, referring to the computer-implemented aspects of the present invention, one or more or all of the method steps of the method according to one or more of the embodiments disclosed herein can be performed by using a computer or a computer network. Thus, in general, any of the method steps including providing and / or manipulating data can be performed by using a computer or a computer network. In general, these method steps can include any method steps, except those that require manual operations such as providing a sample and / or certain aspects of performing the actual measurement.
[0071] Specifically, the present invention further discloses:
[0072] a computer or computer network comprising at least one processor, the processor being configured to execute a method according to one of the embodiments described herein, - a computer-loadable data structure configured, when executed on a computer, to carry out a method according to one of the embodiments described herein, a computer program adapted to carry out a method according to one of the embodiments described in this specification while said program is being run on a computer, a computer program comprising program means for carrying out the method according to one of the embodiments described herein when said computer program is run on a computer or on a computer network, a computer program comprising program means according to any of the preceding embodiments stored on a computer readable storage medium; a storage medium, on which a data structure is stored and adapted to carry out a method according to one of the embodiments described herein after the data structure has been loaded into a main and / or working storage of a computer or a computer network, - a computer program product having program code means, which program code means may be or is stored on a storage medium for performing a method according to one of the embodiments described in this specification when the program code means is executed on a computer or a computer network.
[0073] In summary of the findings of the present invention, the following embodiments are specifically envisaged.
[0074] Embodiment 1: A method for labeling an analyte in a sample, the method comprising: (a) providing a detection reagent that binds to the analyte and conjugating the detection reagent with an indicator reagent to form a conjugation product; (b) contacting the sample with the conjugation product of step (a), (c) The method, wherein step (b) is carried out immediately after completion of step (a).
[0075] Embodiment 2: The method of embodiment 1, wherein immediately performing comprises performing step (b) up to 1 day, in one embodiment up to 12 hours, in a further embodiment up to 6 hours, in a further embodiment up to 3 hours, and in a further embodiment up to 1 hour, after completion of step (a).
[0076] Embodiment 3: The method of embodiment 1 or 2, wherein the conjugating step (a) is carried out in a first reaction vessel and immediately carrying out comprises contacting the conjugate from step (a) with the sample in a second reaction vessel, and wherein the conjugate from step (a) is not contacted with any additional vessel prior to step (b).
[0077] Embodiment 4: The method of any one of embodiments 1 to 3, wherein the detection agent is an antibody or a fragment thereof.
[0078] Embodiment 5: The method of any one of embodiments 1 to 4, wherein the coupling between the detection reagent and the indicator reagent is non-covalent, in one embodiment, via an affinity pair, or covalent, in one embodiment, via an amide or disulfide group.
[0079] Embodiment 6: The method of any one of embodiments 1 to 5, wherein the conjugation is carried out in a first reaction vessel in step (a) and the conjugation product is transferred from the first reaction vessel to a second reaction vessel.
[0080] Embodiment 7: The method of any one of embodiments 1 to 6, wherein the method comprises the additional step (a1) of providing an additional detection reagent that binds to an additional analyte, and the additional step of conjugating the additional detection reagent with an additional indicator reagent to produce an additional conjugation product, and step (b) comprises contacting the sample with the conjugation product of step (a) and the additional conjugation product of step (a1), and step (b) is performed immediately after completion of at least one of the providing and conjugating steps.
[0081] Embodiment 8: The method of step 7, wherein the conjugating step (a) is carried out in a first reaction vessel and step (a1) is carried out in a third reaction vessel, and immediately performing comprises contacting the conjugate from steps (a) and (a1) with the sample in the second reaction vessel, and wherein the conjugate from step (a) and / or the conjugate from step (a1) is not contacted with any further vessel prior to step (c).
[0082] Embodiment 9: The method of embodiment 7 or 8, further comprising at least one further step (a2) of providing a further detection reagent that binds to a further analyte, and a further step of conjugating said further detection reagent with a further indicator reagent to produce a further conjugation product, wherein step (b) comprises contacting said sample with said conjugation product of step (a), an additional conjugation product of step (a1), and at least one further conjugation product of step (a2), and wherein step (b) is performed immediately after completion of at least one of said providing and conjugating steps.
[0083] Embodiment 10: The method of any one of embodiments 1 to 9, wherein the analyte is a cell surface marker.
[0084] Embodiment 11: The method according to any one of embodiments 7 to 10, wherein the additional analyte is optionally any further analyte(s), a further cell surface marker.
[0085] Embodiment 12: The method of any one of embodiments 7 to 11, wherein the detection agent and the additional detection agent, and optionally any further detection agents, are not identical to each other.
[0086] Embodiment 13: The method of any one of embodiments 7 to 12, wherein the indicator and the additional indicator, and optionally any further indicators, are not identical to each other.
[0087] Embodiment 14: The method of any one of embodiments 7 to 13, wherein the indicator, the additional indicator, and optionally any further indicator(s) are non-identical dyes, and in one embodiment non-identical fluorophores.
[0088] Embodiment 15: The method of any one of embodiments 7 to 14, wherein the method comprises selecting the indicator and the additional indicator, and optionally any further indicators, such that interference between the indicators is reduced.
[0089] Embodiment 16: The method of any one of embodiments 7 to 15, wherein the interference is selected from the list consisting of fluorescence spillover, absorption spectrum overlap, and cross-excitation.
[0090] Embodiment 17: The method of any one of embodiments 1 to 16, wherein the sample is a biological sample.
[0091] Embodiment 18: The method of any one of embodiments 1 to 17, wherein said sample comprises cells, in one embodiment human cells.
[0092] Embodiment 19: The method according to any one of embodiments 1 to 18, implemented on a device according to any one of embodiments 24 to 35.
[0093] Embodiment 20: The method of any one of embodiments 1 to 19, wherein the conjugating comprises the formation of a non-covalent association product of the affinity pair or comprises the formation of at least one covalent bond.
[0094] Embodiment 21: A method for labeling at least two analytes in said sample, comprising: (aa) providing a first detection reagent that binds to a first analyte and conjugating the first detection reagent with a first indicator reagent to form a first conjugation product; (bb) providing a second detection reagent that binds to a second analyte and conjugating said second detection reagent with a second indicator reagent to form a second conjugation product; (cc) contacting the sample with the first conjugation product of step (aa) and the second conjugation product of step (bb); The method, wherein step (cc) is carried out immediately after completion of step (bb).
[0095] Embodiment 22: A method for labeling at least two analytes in said sample, comprising: (aaa) providing a first detection reagent that binds to a first analyte and conjugating said first detection reagent with a first indicator reagent to generate a first conjugation product, and / or providing a predetermined conjugate product that is a predetermined detection reagent conjugated to a predetermined indicator reagent; (bbb) providing a second detection reagent that binds to a second analyte and conjugating the second detection reagent with a second indicator reagent to form a second conjugation product; (ccc) contacting the sample with the first conjugation product and / or the predetermined conjugation product of step (aaa), and the second conjugation product of step (bbb); The method, wherein step (ccc) is carried out immediately after completion of step (bbb).
[0096] Embodiment 23: The method according to embodiment 21 or 22, further comprising the features according to any one of embodiments 1 to 20.
[0097] Embodiment 24: A marking device, comprising: (A) a first container containing a detection reagent, operably connected to a reaction unit; (B) a second container containing an indicator, operably connected to the reaction unit; (C) a label unit; A labeling device, wherein the reaction unit is configured to conjugate the detection reagent with the indicator reagent to generate a conjugation product, and the labeling unit is configured to contact a sample with the conjugation product.
[0098] Embodiment 25: The labeling apparatus of embodiment 24, wherein the reaction unit comprises a first reaction vessel and optionally a second vessel.
[0099] Embodiment 26: The labeling apparatus of embodiment 24 or 25, wherein the reaction unit further comprises an independently selected heating unit, a cooling unit, one or more co-reactant(s) and / or catalyst(s), a buffer, a diluent and / or a stopper, an agitator, a shaker and / or a pipetting unit.
[0100] Embodiment 27: The labeling apparatus of any one of embodiments 24 to 26, wherein the labeling unit further comprises a heating unit, a cooling unit, one or more co-reactant(s) and / or catalyst(s), a buffer, a diluent and / or a stopper, an agitator, a shaker, a pipetting unit.
[0101] Embodiment 28: A labeling device according to any one of embodiments 24 to 27, wherein the labeling unit is operably connected to an analysis unit comprising a detector.
[0102] Embodiment 29: The labeling device of embodiment 28, wherein the detector is adapted to detect a conjugation product.
[0103] Embodiment 30: A labeling device according to any one of embodiments 24 to 29, wherein the detector comprises a FACS unit or a digital imaging unit.
[0104] Embodiment 31: A signage device according to any one of embodiments 24 to 30, further comprising a selector unit.
[0105] Embodiment 32: A labeling device as described in any one of embodiments 24 to 24, wherein the selector unit includes a tangibly embodied algorithm for selecting an indicator for conjugation with a detection agent, in one embodiment for selecting at least a first indicator for conjugation with a first detection agent and a second indicator for conjugation with a second detection agent.
[0106] Embodiment 33: A labeling device described in any one of embodiments 24 to 32, wherein the selector unit further comprises a database, in one embodiment tangibly embodied, containing data regarding indicator compounds assigned to interfering indicator compounds and / or data regarding interference.
[0107] Embodiment 34: A marking device as described in any one of embodiments 24 to 33, adapted to perform the method as described in any one of embodiments 1 to 23.
[0108] Embodiment 35: A signage device as described in any one of embodiments 24 to 34, further comprising a processor and instructions, tangibly embodied in one embodiment, that when executed on the processor cause the device to perform the method as described in any one of embodiments 1 to 23.
[0109] Embodiment 36: A system, comprising: (i) a signage device according to any one of embodiments 24 to 35; (ii) a detection device and / or a selector device; A system comprising:
[0110] Embodiment 37: The system described in embodiment 36, wherein the detection device comprises a detector described in any one of embodiments 28 to 30.
[0111] Embodiment 38: The system described in embodiment 36 or 37, wherein the detection device is a FACS device or a digital imaging device.
[0112] Embodiment 39: A system described in any one of embodiments 36 to 38, wherein the detection device is connected to the marking device by a fluid connection.
[0113] Embodiment 40: A system described in any one of embodiments 36 to 38, wherein the selector device comprises a selector unit described in any one of embodiments 31 to 33.
[0114] Embodiment 41: A computer-implemented method for selecting at least two indicator reagents for labeling two analytes with two detection reagents, comprising: (a) obtaining data on available indicators; and (b) obtaining data regarding one or more analytes; (c) selecting at least two indicators based on said data obtained in steps (I) and (II), said selection comprising: - Reducing or preventing fluorescence spillover, - reducing or preventing overlap of absorption spectra, and - reducing or preventing cross-excitation. - selecting at least two indicators based on the data obtained in steps (I) and (II), the indicators satisfying at least one condition from the list consisting of:
[0115] Embodiment 42: Use of on-board conjugation to generate at least two detection reagents comprising non-identical indicators on an apparatus comprising an analysis unit and a detector.
[0116] Embodiment 43: The use according to embodiment 42, wherein the analysis unit is an analysis unit as specified in embodiment 28 or 29.
[0117] Embodiment 44: The use according to embodiment 42 or 43, wherein the detector is a detector according to any one of embodiments 28 to 30.
[0118] Embodiment 45: The use according to any one of embodiments 42 to 44, wherein the device comprises a FACS unit.
[0119] All references mentioned in this specification are hereby incorporated by reference with respect to their entire disclosure content and the disclosure content specifically mentioned in this specification. [Brief description of the drawings]
[0120] [Figure 1] 1 is a schematic diagram of a marking device 100. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0121] The following examples are merely illustrative of the present invention and should not be construed as limiting the scope of the present invention in any way.
[0122] 1, the labeling device 100 of the present invention may comprise a first detector reservoir 102 and a second detector reservoir 112, a first, second and third indicator reservoirs 104, 114, 124, a first, second and third reaction vessels 106, 116 and 150, and a sample vessel 140 connected by a fluid connection 130, as shown in FIG. 1. As will be appreciated by those skilled in the art, the fluid connection may be embodied as tubing, but also as a fluid connection provided by a pipetting device, i.e., the fluid connection 130 does not have to be permanent.
[0123] Example 1: Flexibility of using a single indicator In use, the first detection reagent can be transferred from its container 102 to the first reaction container 106, and the first indicator reagent can be transferred from its container 104 to the first reaction container 106, where the detection reagent and the indicator reagent are conjugated, and after conjugation is completed, the conjugate is transferred to the second reaction container 150, to which the sample is further added from its container 140.
[0124] For example, if the first indicator reagent is no longer available because it has run out or reached its expiration date, the method may be carried out as described above, but with the second indicator reagent transferred from its container 114 to the first reaction container 106, thus providing a replacement conjugate.
[0125] Example 2: Interference Avoidance 1, dual labeling may be achieved by transferring a first detection agent from its container 102 to a first reaction container 106, transferring a first indicator agent from its container 104 to the first reaction container 106, where the first detection agent and the first indicator agent are conjugated, and after completion of conjugation, transferring the resulting first conjugate to a second reaction container 150. Further, a second detection agent is transferred from its container 112 to a third reaction container 116, a second indicator agent is transferred from its container 114 to the third reaction container 116, where the second detection agent and the second indicator agent are conjugated, and after completion of conjugation, transferring the resulting second conjugate to a second reaction container 150, and then adding a sample from its container 140, thus achieving dual labeling.
[0126] If it is recognized that the combination of the first and second indicator dyes results in interference, for example, the second indicator dye may be replaced by a third indicator dye from its container 124, improving the indication.
[0127] Example 3: Flexibility As known to those skilled in the art, for example in a TBNK analysis (analysis of T, B and NK cells) the markers CD3, CD4, CD8, CD45, CD56, CD16 and / or CD19 may be determined, so that at least one detection agent is required for each of said markers (Table 1). Commonly used indicators are also shown, for example, in Table 2. [Table 1] [Table 2]
[0128] To stock any possible combination of detection agents and indicator agents from Tables 1 and 2, 7×9=63 detection agent / indicator conjugates would need to be stocked separately with the associated labor and costs. According to the claimed subject matter, only 7 detection agents and 9 indicator agents need to be stocked since the required combinations can be conjugated on-board.
[0129] literature Barnett et al. (2009), Nat Rev Microbiol 6(11 Suppl):S7 Ouyang et al. (2019), J Int Med Res 47(4):1483 U.S. Patent No. 9,017,610B2 [Explanation of symbols]
[0130] 100 marking device 102 First detection drug reservoir 104 First indicator reservoir 106 First Reaction Vessel 112 Second detection drug reservoir 114 Second indicator reservoir 116 Third Reaction Vessel 124 3rd indicator reservoir 130 Fluid connections, e.g. tubes 140 Sample Container 150 Second Reaction Vessel
Claims
1. 1. A method for labeling an analyte in a sample, the method comprising: (a) providing a detection reagent that binds to the analyte and conjugating the detection reagent with an indicator reagent to form a conjugation product; (b) contacting the sample with the conjugation product of step (a), A method wherein step (b) is performed immediately following completion of step (a), and wherein steps (a) and (b) are performed by the same labeling device.
2. 2. The method of claim 1, wherein immediately performing comprises performing step (b) up to 1 day, in one embodiment up to 12 hours, in a further embodiment up to 6 hours, in a further embodiment up to 3 hours, and in a further embodiment up to 1 hour, after completion of step (a).
3. 3. The method of claim 1 or 2, wherein the conjugating step (a) is carried out in a first reaction vessel and immediately carrying out comprises contacting the conjugate from step (a) with the sample in a second reaction vessel, and wherein the conjugate from step (a) is not contacted with any additional vessel prior to step (b).
4. The method of any one of claims 1 to 3, wherein the detection agent is an antibody or a fragment thereof.
5. The method according to any one of claims 1 to 4, wherein the sample is a biological sample, in one embodiment a sample comprising cells.
6. The method according to any one of claims 1 to 5, wherein the coupling between the detection reagent and the indicator reagent is non-covalent, in one embodiment via an affinity pair.
7. 7. The method of any one of claims 1 to 6, wherein the method comprises the additional step (a1) of providing an additional detection reagent that binds to an additional analyte, and the additional step of conjugating the additional detection reagent with an additional indicator reagent to produce an additional conjugation product, and step (b) comprises contacting the sample with the conjugation product of step (a) and the additional conjugation product of step (a1), and step (b) is performed immediately after completion of at least one of the providing and conjugating steps.
8. 8. The method of any one of claims 1 to 7, wherein the method comprises selecting the indicator and the additional indicator, and optionally any further indicators, such that interference between the indicators is reduced, in an embodiment the interference is selected from the list consisting of: fluorescence spillover, overlapping absorption spectra, cross-excitation.
9. The method according to any one of claims 1 to 8, wherein the marking device is a marking device according to any one of claims 10 to 13.
10. 1. A signage device, comprising: (A) a first container containing a detection reagent, operably connected to a reaction unit; (B) a second container containing an indicator, operably connected to the reaction unit; and (C) a label unit, the reaction unit is configured to conjugate the detection reagent with the indicator reagent to generate a conjugation product, and the labeling unit is configured to contact a sample with the conjugation product; The marking device further comprises a processor and tangibly embodied instructions which, when executed on the processor, cause the marking device to perform the method of any one of claims 1 to 8.
11. The marking device of claim 10 further comprising an analysis unit comprising a detector.
12. The marking device of claim 11 , wherein the detector comprises a FACS unit or a digital imaging unit.
13. The labelling device of any one of claims 10 to 12, further comprising a selector unit including a tangibly embodied algorithm for selecting an indicator reagent for conjugation with a detection reagent.
14. A system operatively connected (i) a signage device according to any one of claims 10 to 13; (ii) a detection device and / or a selector device; A system comprising:
15. The use of on-board conjugation to generate at least two detection reagents, including non-identical indicator reagents, on an apparatus comprising an analytical unit and a detector.
